The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Indirubin and Indigo Are Potent Aryl Hydrocarbon Receptor Ligands Present in Human Urine
Open accessAbstract
Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that regulates genes involved in xenobiotic metabolism, cellular proliferation, and differentiation. Numerous xenobiotic and biological compounds are known to interact with AhR, but it remains an orphan receptor, because its physiological ligand is unknown. We identified AhR ligands in human urine using a yeast AhR signaling assay and then characterized their properties. Two ligands, indirubin and indigo, were both present at average concentrations of approximately 0.2 nm in the urine of normal donors. Indirubin was also detected in fetal bovine serum and contributed half of the total AhR ligand activity. The activities of indirubin and indigo were comparable with or more potent than that of the archetypal ligand, 2,3,7,8-tetrachlorodibenzo-p-dioxin, in yeast AhR activation assays. We suggest that the endogenous levels and potencies of indirubin and indigo are such that they activate AhR-mediated signaling mechanisms in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, Indirubin demonstrated the strongest binding to AHR among these ligands, consistent with previous reports45,46.”
From Structural basis for the ligand-dependent activation of heterodimeric AHR-ARNT complex (2025) · cites this paper as [45]
Citations
Cites
The Aryl Hydrocarbon Receptor Complex
Hankinson, O. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.001515 · Cited by 1,649
Hoessel, R., Leclerc, S., Endicott, J., Nobel, M. E. M., Lawrie, A. M., Tunnah, P., Leost, M., Damiens, E., Marie, D., Marko, D., et al. (1999) · Nature Cell Biology · doi:10.1038/9035 · Cited by 816
Pohjanvirta, R., & Tuomisto, J. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06814-0 · Cited by 472
Kolluri, S. K., Weiss, C., Koff, A., & Göttlicher, M. (1999) · Genes & Development · doi:10.1101/gad.13.13.1742 · Cited by 364
Puga, A., Barnes, S., Dalton, T. P., Chang, C., Knudsen, E. S., & Maier, M. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2943 · Cited by 315
Oxidation of Indole by Cytochrome P450 Enzymes
Gillam, E. M. J., Notley, L. M., Cai, H., De Voss, J. J., & Guengerich, F. P. (2000) · Biochemistry · doi:10.1021/bi001229u · Cited by 313
Lipoxin A4: A New Class of Ligand for the Ah Receptor
Schaldach, C., Riby, J. E., & Bjeldanes, L. F. (1999) · Biochemistry · doi:10.1021/bi982861e · Cited by 272
A Direct Interaction between the Aryl Hydrocarbon Receptor and Retinoblastoma Protein
Ge, N.-L., & Elferink, C. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22708 · Cited by 258
Sinal, C. J., & Bend, J. R. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.4.590 · Cited by 256
Molecular biology of the aromatic hydrocarbon (dioxin) receptor
Okey, A. B., Riddick, D. S., & Harper, P. A. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90316-6 · Cited by 236
Flagged first, then by citations
Research works printed but not linked: 4
- Pohjanvirta, 1994, Pharmacol. Rev., 46, 483
- Gonzalez, 1998, Drug Metab. Dispos., 12, 1194
- Miller, 1997, J. Biol. Chem., 272, 32829
- Blanz, 1989, Res. Commun. Chem. Pathol. Pharmacol., 64, 145
Cited by
Sorted by citations
Denison, M. S., & Nagy, S. R. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135828 · Cited by 1,895
Impact of Natural Products on Developing New Anti-Cancer Agents
Cragg, G. M. L., Grothaus, P. G., & Newman, D. J. (2009) · Chemical Reviews · doi:10.1021/cr900019j · Cited by 1,326
Regulation of the immune response by the aryl hydrocarbon receptor
Gutiérrez-Vázquez, C., & Quintana, F. J. (2018) · Immunity · doi:10.1016/j.immuni.2017.12.012 · Cited by 985
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Murray, I. A., Patterson, A. D., & Perdew, G. H. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3846 · Cited by 916
GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins
Meijer, L., Skaltsounis, A., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X. P., Vonica, A., Brivanlou, A. H., Dajani, R., et al. (2003) · Chemistry & Biology · doi:10.1016/j.chembiol.2003.11.010 · Cited by 814
Functional role of AhR in the expression of toxic effects by TCDD
Mimura, J., & Fujii‐Kuriyama, Y. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00485-3 · Cited by 754
The Search for Endogenous Activators of the Aryl Hydrocarbon Receptor
Nguyen, L. P., & Bradfield, C. A. (2007) · Chemical Research in Toxicology · doi:10.1021/tx7001965 · Cited by 718
Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation
Hubbard, T. D., Murray, I. A., & Perdew, G. H. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064246 · Cited by 670
DiNatale, B. C., Murray, I. A., Schroeder, J. C., Flaveny, C. A., Lahoti, T. S., Laurenzana, E. M., Omiecinski, C. J., & Perdew, G. H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq024 · Cited by 651
AhR signaling pathways and regulatory functions
Larigot, L., Juricek, L., Dairou, J., & Coumoul, X. (2018) · Biochimie Open · doi:10.1016/j.biopen.2018.05.001 · Cited by 563
Westerink, W. M. A., & Schoonen, W. G. E. J. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.05.014 · Cited by 544
The Aryl Hydrocarbon Receptor in Barrier Organ Physiology, Immunology, and Toxicology
Esser, C., & Rannug, A. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009001 · Cited by 501
Ligand binding and activation of the Ah receptor
Denison, M. S., Pandini, A., Nagy, S. R., Baldwin, E. P., & Bonati, L. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00063-7 · Cited by 485
Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases
Mazanetz, M. P., & Fischer, P. M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2111 · Cited by 459
Understanding the human health effects of chemical mixtures.
Carpenter, D. O., Arcaro, K. F., & Spink, D. C. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110s125 · Cited by 437
The aryl hydrocarbon receptor, more than a xenobiotic‐interacting protein
Barouki, R., Coumoul, X., & Fernández‐Salguero, P. M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.046 · Cited by 398
Polychronopoulos, P., Magiatis, P., Skaltsounis, A., Myrianthopoulos, V., Mikros, E., Tarricone, A., Musacchio, A., Roe, S. M., Pearl, L. H., Leost, M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031016d · Cited by 382
(CONTAM), E. P. O. C. I. T. F. C., Knutsen, H. K., Alexander, J., Barregård, L., Bignami, M., Brüschweiler, B. J., Ceccatelli, S., Cottrill, B., Dinovi, M., Edler, L., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5333 · Cited by 378
Aryl Hydrocarbon Receptor Control of Adaptive Immunity
Quintana, F. J., & Sherr, D. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007823 · Cited by 350
The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment
Shinde, R. S., & McGaha, T. L. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.10.010 · Cited by 340
An introduction to the molecular basics of aryl hydrocarbon receptor biology
Abel, J., & Haarmann‐Stemmann, T. (2010) · Biological Chemistry · doi:10.1515/bc.2010.128 · Cited by 309
A Novel Role for the Dioxin Receptor in Fatty Acid Metabolism and Hepatic Steatosis
Lee, J. H., Wada, T., Febbraio, M., He, J., Matsubara, T., Lee, M. J., Gonzalez, F. J., & Xie, W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.033 · Cited by 277
A ligand for the aryl hydrocarbon receptor isolated from lung
Song, J., Clagett‐Dame, M., Peterson, R. E., Hahn, M. E., Westler, W. M., Siciński, R. R., & DeLuca, H. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232562899 · Cited by 264
Endogenous and Exogenous Ligands of Aryl Hydrocarbon Receptor: Current State of Art
Stejskalová, L., Dvořák, Z., & Pávek, P. (2011) · Current Drug Metabolism · doi:10.2174/138920011795016818 · Cited by 231
Westerink, W. M. A., & Schoonen, W. G. E. J. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.06.017 · Cited by 226
Cytochrome p450 enzymes in the generation of commercial products
Guengerich, F. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd792 · Cited by 223
Guengerich, F. P. (2007) · Springer eBooks · doi:10.1007/0-387-27447-2_10 · Cited by 226
Kawajiri, K., & Fujii-Kuriyama, Y. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.03.038 · Cited by 197
Pocar, P., Fischer, B., Klonisch, T. C., & Hombach‐Klonisch, S. (2005) · Reproduction · doi:10.1530/rep.1.00294 · Cited by 197
Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders
Busbee, P. B., Rouse, M. D., Nagarkatti, M., & Nagarkatti, P. S. (2013) · Nutrition Reviews · doi:10.1111/nure.12024 · Cited by 197
The Aryl Hydrocarbon Receptor sans Xenobiotics: Endogenous Function in Genetic Model Systems
McMillan, B. J., & Bradfield, C. A. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.037259 · Cited by 183
Vyhlídalová, B., Krasulová, K., Pečinková, P., Marcalíková, A., Vrzal, R., Zemánková, L., Vančo, J., Trávnı́ček, Z., Vondráček, J., Karasová, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072614 · Cited by 176
The Aryl Hydrocarbon Receptor and Tumor Immunity
Xue, P., Fu, J., & Zhou, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00286 · Cited by 168
Liang, C., Xia, J., Dong, L., Li, X. O., Yao, Q., & Gao, J. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.04.040 · Cited by 152
Karchner, S. I., Franks, D. G., & Hahn, M. E. (2005) · Biochemical Journal · doi:10.1042/bj20050713 · Cited by 151
Guengerich, F. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_9 · Cited by 159
AhR and ARNT modulate ER signaling
Swedenborg, E., & Pongratz, I. (2009) · Toxicology · doi:10.1016/j.tox.2009.09.007 · Cited by 153
Role of the aryl hydrocarbon receptor in drug metabolism
Ramadoss, P., Marcus, C. B., & Perdew, G. H. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.1.9 · Cited by 147
Modulation of benzo[a]pyrene–DNA adduct formation by CYP1 inducer and inhibitor
Shiizaki, K., Kawanishi, M., & Yagi, T. (2017) · Genes and Environment · doi:10.1186/s41021-017-0076-x · Cited by 148
Moon, M. J., Lee, S. K., Lee, J., Song, W. K., Kim, S. W., Kim, J. I., Cho, C., Choi, S. J., & Kim, Y. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.08.008 · Cited by 135
Singh, N. P., Singh, U. P., Rouse, M. D., Zhang, J., Chatterjee, S., Nagarkatti, P. S., & Nagarkatti, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501727 · Cited by 140
Role of AHR Ligands in Skin Homeostasis and Cutaneous Inflammation
Fernández‐Gallego, N., Sánchez‐Madrid, F., & Cibrián, D. (2021) · Cells · doi:10.3390/cells10113176 · Cited by 138
Choi, H. S., Kim, J. K., Cho, E. H., Kim, Y. C., Kim, J. I., & Kim, S. W. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01087-8 · Cited by 131
Kawajiri, K., & Fujii‐Kuriyama, Y. (2016) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.16-0092 · Cited by 137
Guo, B., Bian, Z., Qiu, H.-C., Wang, Y., & Wang, Y. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13414 · Cited by 132
Cell Density Regulates Intracellular Localization of Aryl Hydrocarbon Receptor
Ikuta, T., Kobayashi, Y., & Kawajiri, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310492200 · Cited by 125
Hrycay, E. G., & Bandiera, S. M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16009-2_1 · Cited by 132
Rui, L., Reardon, K. F., & Wood, T. K. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1698-z · Cited by 125
Takamura, T., Harama, D., Fukumoto, S., Nakamura, Y., Shimokawa, N., Ishimaru, K., Ikegami, S., Makino, S., Kitamura, M., & Nakao, A. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2010.165 · Cited by 127
Smirnova, A. V., Wincent, E., Bergander, L. V., Alsberg, T. E., Bergman, J., Rannug, A., & Rannug, U. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00416 · Cited by 125
Timing is everything: Consequences of transient and sustained AhR activity
Mitchell, K. A., & Elferink, C. J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.028 · Cited by 120
Microarray analysis of the AHR system: Tissue-specific flexibility in signal and target genes
Frericks, M., Meissner, M., & Esser, C. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.01.014 · Cited by 124
Rannug, A., & Rannug, U. (2018) · Critical Reviews in Toxicology · doi:10.1080/10408444.2018.1493086 · Cited by 126
Kawai, S., Iijima, H., Shinzaki, S., Hiyama, S., Yamaguchi, T., Araki, M., Iwatani, S., Shiraishi, E., Mukai, A., Inoue, T., et al. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1292-z · Cited by 120
Sethi, G., Ahn, K. S., Sandur, S. K., Lin, X., Chaturvedi, M. M., & Aggarwal, B. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602627200 · Cited by 113
Mayser, P., & Gaitanis, G. (2010) · Springer eBooks · doi:10.1007/978-3-642-03616-3_4 · Cited by 114
Rouse, M. D., Singh, N. P., Nagarkatti, P. S., & Nagarkatti, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12205 · Cited by 113
Mukai, M., & Tischkau, S. A. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl126 · Cited by 110
Pharmacological properties of indirubin and its derivatives
Lin, Y., Li, X., Huang, W., Rao, X., & Lai, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113112 · Cited by 109
How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression
Wang, Z., Snyder, M., Kenison, J. E., Yang, K., Lara, B., Lydell, E., Bennani, K., Novikov, O., Federico, A. N., Monti, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010387 · Cited by 120
Dioxins, the aryl hydrocarbon receptor and the central regulation of energy balance
Lindén, J., Lensu, S., Tuomisto, J., & Pohjanvirta, R. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.07.002 · Cited by 108
Henry, E. C., Bemis, J. C., Henry, O., Kende, A. S., & Gasiewicz, T. A. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.02.008 · Cited by 107
Denison, M. S. (2004) · Talanta · doi:10.1016/j.talanta.2004.05.032 · Cited by 110
Nagayoshi, H., Kakimoto, K., Takagi, S., Konishi, Y., Kajimura, K., & Matsuda, T. (2014) · Environmental Science & Technology · doi:10.1021/es503926w · Cited by 110
Self-citationAryl Hydrocarbon Receptor and Its Diverse Ligands and Functions: An Exposome Receptor
Larigot, L., Benoit, L., Koual, M., Tomkiewicz, C., Barouki, R., & Coumoul, X. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052220-115707 · Cited by 117
Medjakovic, S., & Jungbauer, A. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.10.001 · Cited by 103
7-Bromoindirubin-3′-oxime induces caspase-independent cell death
Ribas, J., Bettayeb, K., Ferandin, Y., Knockaert, M., Garrofé-Ochoa, X., Totzke, F., Schächtele, C., Mešter, J., Polychronopoulos, P., Magiatis, P., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209648 · Cited by 105
Bruner‐Tran, K. L., Gnecco, J. S., Ding, T., Glore, D. R., Pensabene, V., & Osteen, K. G. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.07.007 · Cited by 108
Metabolic fate of the Ah receptor ligand 6-formylindolo[3,2-b]carbazole
Bergander, L. V., Wincent, E., Rannug, A., Foroozesh, M. K., Alworth, W. L., & Rannug, U. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.08.005 · Cited by 103
Bock, K. W., & Köhle, C. (2009) · Biological Chemistry · doi:10.1515/bc.2009.138 · Cited by 102
Jonsson, E., Abrahamson, A., Brunström, B., & Brandt, I. (2006) · Aquatic Toxicology · doi:10.1016/j.aquatox.2006.06.006 · Cited by 101
Mulero‐Navarro, S., Pozo‐Guisado, E., Pérez-Mancera, P. A., Alvarez, A. M., Catalina‐Fernández, I., Hernández‐Nieto, E., Sáenz‐Santamaría, J., Martínez, N., Rojas, J. M., Sánchez-Garcı́a, I., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504538200 · Cited by 100
Zhang, S., Kim, K., Jin, U. H., Pfent, C. M., Cao, H., Amendt, B. A., Liu, X., Wilson-Robles, H. M., & Safe, S. H. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0548 · Cited by 100
Knockaert, M., Blondel, M., Bach, S., Leost, M., Elbi, C., Hager, G. L., Nagy, S. R., Han, D., Denison, M. S., Ffrench, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207535 · Cited by 98
Matsuda, S., Adachi, J., Ihara, M., Tanuma, N., Shima, H., Kakizuka, A., Ikura, M., Ikura, T., & Matsuda, T. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv967 · Cited by 95
Self-citationAmakura, Y., Tsutsumi, T., Sasaki, K., Nakamura, M., Yoshida, T., & Maitani, T. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.07.022 · Cited by 97
Aryl hydrocarbon receptor response to indigoids in vitro and in vivo
Guengerich, F. P., Martin, M. V., McCormick, W. A., Nguyen, L. P., Glover, E. A., & Bradfield, C. A. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.01.002 · Cited by 99
Regulation of CYP1A1 by heavy metals and consequences for drug metabolism
Anwar‐Mohamed, A., Elbekai, R. H., & El‐Kadi, A. O. S. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902918302 · Cited by 93
Urolithin A Is a Dietary Microbiota-Derived Human Aryl Hydrocarbon Receptor Antagonist
Muku, G. E., Murray, I. A., Espı́n, J. C., & Perdew, G. H. (2018) · Metabolites · doi:10.3390/metabo8040086 · Cited by 94
The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulation
Polonio, C. M., McHale, K. A., Sherr, D. H., Rubenstein, D., & Quintana, F. J. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01172-x · Cited by 104
Anti-inflammatory effects of the extract of indigo naturalis in human neutrophils
Lin, Y., Leu, Y., Huang, T., Wu, Y., Chung, P.-J., Pang, J. S., & Hwang, T. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.06.014 · Cited by 91
Wada, T., Sunaga, H., Miyata, K., Shirasaki, H., Uchiyama, Y., & Shimba, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.693655 · Cited by 97
Hu, P., Herrmann, R., Bednar, A., Saloupis, P., Dwyer, M. A., Yang, P., Qi, X., Thomas, R. S., Jaffe, G. J., Boulton, M. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307574110 · Cited by 93
Modulating AHR function offers exciting therapeutic potential in gut immunity and inflammation
Chen, Y., Wang, Y., Fu, Y., Yin, Y., & Xu, K. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01046-y · Cited by 92
Andrieux, L. O., Langouët, S., Fautrel, A., Ezan, F., Krauser, J. A., Savouret, J. F., Guengerich, F. P., Baffet, G., & Guillouzo, A. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.934 · Cited by 85
He, G., Tsutsumi, T., Zhao, B., Baston, D. S., Zhao, J., Heath‐Pagliuso, S., & Denison, M. S. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr189 · Cited by 84
Levine, A., Chen, L., & Elferink, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.2.461 · Cited by 84
Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases
Blažević, T., Heiß, E. H., Atanasov, A. G., Breuss, J. M., Dirsch, V. M., & Uhrín, P. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/654098 · Cited by 87
Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin
Spink, B. C., Hussain, M. M., Katz, B. H., Eisele, L. E., & Spink, D. C. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.019 · Cited by 85
From the Insoluble Dye Indirubin towards Highly Active, Soluble CDK2‐Inhibitors
Jautelat, R., Brumby, T., Schäfer, M., Briem, H., Eisenbrand, G., Schwahn, S., Krüger, M., Lücking, U., Prien, O., & Siemeister, G. (2005) · ChemBioChem · doi:10.1002/cbic.200400108 · Cited by 80
Random Mutagenesis of Human Cytochrome P450 2A6 and Screening with Indole Oxidation Products1
Nakamura, K., Martin, M. V., & Guengerich, F. P. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2569 · Cited by 80
Tarnow, P., Tralau, T., & Luch, A. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1569627 · Cited by 79
Sugihara, K., Kitamura, S., Yamada, T., Okayama, T., Ohta, S., Yamashita, K. H., Yasuda, M., Fujii‐Kuriyama, Y., Saeki, K., Matsui, S., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.066 · Cited by 77
Self-citationBen‐Horin, S., Salomon, N., Karampekos, G., Viazis, N., Lahat, A., Ungar, B., Eliakim, R., Kuperstein, R., Kriger-Sharabi, O., Mintz, H. R., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.05.023 · Cited by 75
Amakura, Y., Tsutsumi, T., Nakamura, M., Kitagawa, H., Fujino, J., Sasaki, K., TOYODA, M., Yoshida, T., & Maitani, T. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.532 · Cited by 73
Self-citationPotential Health-modulating Effects of Isoflavones and Metabolites via Activation of PPAR and AhR
Medjakovic, S., Mueller, M., & Jungbauer, A. (2010) · Nutrients · doi:10.3390/nu2030241 · Cited by 76
Induction of cytochrome P450 enzymes: a view on human in vivo findings
Hukkanen, J. (2012) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.39 · Cited by 74
Wang, H., Wang, Z., Wei, C., Wang, J., Xu, Y., Bai, G., Yao, Q., Zhang, L., & Chen, Y. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113652 · Cited by 70
Guengerich, F. P., Sorrells, J. L., Schmitt, S., Krauser, J. A., Aryal, P., & Meijer, L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030561b · Cited by 70
Esser, C. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.002 · Cited by 74
Metadata
- Authors
- Adachi, J., Mori, Y., Matsui, S., Takigami, H., Fujino, J., Kitagawa, H., Miller, C. A., Kato, T., Saeki, K., & Matsuda, T.
- Affiliations
- Kyoto University (JP)
- Tulane University (US)
- Nagoya City University (JP)
- Corresponding author
- Matsuda, Tomonari
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-08
- Volume
- 276
- Issue
- 34
- Pages
- 31475-31478
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1989060543
- Cited by
- 407
- References
- 22
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 9 · 2023: 14 · 2022: 21 · 2021: 15 · 2020: 12 · 2019: 16 · 2018: 19 · 2017: 9 · 2016: 18 · 2015: 14 · 2014: 13 · 2013: 20 · 2012: 16
- FWCI
- 15.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Environmental Health Sciences (ES09055, R29ES009055)
- Topics
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Keywords
- aryl hydrocarbon receptor, indirubin, indigo, AhR ligands, human urine, endogenous ligands, 2,3,7,8-tetrachlorodibenzo-p-dioxin, xenobiotic metabolism, transcription factor signaling
- MeSH terms
- Polychlorinated Dibenzodioxins, Humans, Indigo Carmine, Indoles, Ligands, Male, Saccharomyces cerevisiae, Signal Transduction, Genes, Reporter, Receptors, Aryl Hydrocarbon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review